Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Reuters NewMedia - Thursday November 29, 2001
The pact could eventually lead to a merger, the Danish company's chief executive told Reuters.
"If you compare the two companies, it is obvious to merge them," said Bavarian Nordic CFO Bo Sandroos.
"But merging a Danish and an American company is nothing you do from one day to the next, so let's take it easy."
At 1321 GMT, the Bavarian Nordic share soared over 11 percent to a three-week high of 118 crowns on the news.
The HIV vaccine deal calls for a combination of Epimmune's technology and expertise in T-cell epitope (protein fragment) identification and vaccine design with Bavarian Nordic's vaccine delivery technology, the companies said in a statement.
Bavarian Nordic has recently been in the news for its smallpox vaccine, which several western countries have shown interest in since the recent wave of anthrax scares in the United States.
Last month the Danish company's nine-month report showed its equity capital had dwindled to only some 70 million crowns ($8.4 million), sufficient for financing another six months of research before injection of new capital, income from its smallpox vaccine or a merger would be necessary.
Bavarian Nordic was not among companies listed by the U.S. government to supply 155 million smallpox vaccine doses according to an announcement on Wednesday. ($ equals 8.3617 Danish crowns)
011129
RE011149
Copyright © 2001 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .